CANADA – 2025/08/11: In this photo illustration, the Centene Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
SOPA Images/LightRocket via Getty Images
After a period of underperformance, Centene’s stock (NYSE:CNC) has recently seen a strong rebound, rising 6% on September 24 and nearly 20% over the last month. This follows a significant drop in July 2025 after the company withdrew its 2025 financial guidance.
This sharp increase suggests that the stock may have been undervalued, attracting investors who were waiting for a pullback. However, given this recent rally, its competitor, Molina Healthcare, (NYSE:MOH), now appears to be a more attractive investment opportunity.
Molina Healthcare demonstrates more significant revenue growth during key intervals, enhanced profitability, and a comparatively lower valuation than Centene, implying that investing in MOH may be more advantageous.
- MOH’s revenue growth over the Last 12 Months was 16.1%, compared to CNC’s 13.0%.
- Furthermore, its Last 3-Year Average revenue growth stood at 12.8%, surpassing CNC’s 8.9%.
- MOH outperforms in profitability for both timeframes – with an LTM margin of 3.8% and a 3-year average of 4.2%.
CNC delivers health plan coverage and services to under-insured and uninsured individuals via government programs and commercial healthcare products for individuals and employers. MOH offers managed healthcare services to low-income families and individuals through Medicaid, Medicare, Marketplace, and other government initiatives, catering to 5.2 million members across 18 states.
Valuation & Performance Overview
Valuation & Performance Overview
Trefis
MORE FOR YOU
See more revenue details:
See more margin details:
But do these figures reveal the entire narrative? Read Buy or Sell MOH Stock to ascertain if Molina Healthcare’s advantage stands scrutiny or if Centene retains strategic advantages (see Buy or Sell CNC Stock).
That represents one perspective on stocks. Trefis High Quality Portfolio evaluates numerous other factors, aimed at minimizing stock-specific risk while providing opportunity for growth. It has comfortably outperformed its benchmark—a combination of the S&P 500, Russell, and S&P MidCap indexes—and has achieved returns exceeding 91% since its inception.
Historical Market Performance
Historical Market Performance
Trefis
Regardless of how strong the data appears, stock investment is often unpredictable. There’s a risk to consider. Refer to MOH Dip Buyer Analyses and CNC Dip Buyer Analyses to explore how these stocks have experienced drops and recoveries in the past.
Remember, investing in a single stock without comprehensive analysis can be risky. Consider the Trefis Reinforced Value (RV) Portfolio, which has outperformed its all-cap stocks benchmark (combination of the S&P 500, S&P mid-cap, and Russell 2000 benchmark indices) to produce strong returns for investors. Why is that? The quarterly rebalanced mix of large-, mid-, and small-cap RV Portfolio stocks provided a responsive way to make the most of upbeat market conditions while limiting losses when markets head south, as detailed in RV Portfolio performance metrics.